Delisting risk
LICN · NASDAQ · Specialty Business Services

Lichen International (LICN)

Provides China-focused financial, tax-management, software and pre-IPO advisory services.

$1.13
Pre-market−0.06 (−5.04%)
At close$1.19(+1.71%)
Loading prices…

Lichen International LimitedLICNIndustrials

Provides China-focused financial and tax management consulting, enterprise software and maintenance, and pre-IPO advisory services. Financial and taxation solution projects provide most revenue, delivered through PRC subsidiaries using internal consultants and outside experts.

Combines China-focused financial and tax management consulting with software and maintenance, and pre-IPO advisory for companies pursuing U.S. or Hong Kong listings. Consulting work spans cost management, financial risk, financial-information systems, compliance, tax inspection preparation and operating controls; standard projects use an internal team to diagnose, report, train and support implementation.

Operates primarily through PRC subsidiaries, serving listed companies, state-owned enterprises, government authorities and other businesses across multiple regions and industries. Financial and taxation solution services provide most revenue, with work delivered through internal consultants and external experts. Revenue depends on project work customers do not have to renew, competitive pricing from local providers and converted bookkeeping agencies, external-expert and supplier inputs, and PRC rules governing cash transfers, data and overseas securities offerings.

Company facts

CEOYa Li
ListedFeb 6, 2023
ExchangeNASDAQ
HeadquartersXiamen, China
CountryChina
Employees410
CIK0001876766
ISINKYG5479G1165

Market cap$860.9K
EPS (ttm)−$1.35
P/E (ttm)−0.8401
ROE-32.6%
P/B0.2615
P/S0.0351
Dividend yieldDiv yield
Beta0.49vs XLI 1.08

No analyst consensus on record.

EPSReportedEstimate

Apr '26
Reported−$0.77
Estimate
Surprise

RevenueReportedEstimate

Apr '26
Reported$10.3M
Estimate
Surprise
Estimate
Reported−$0.77
Estimate
Reported$10.3M
View details

Debt to equity0.80%
Current ratio772.80%

ProfitabilityRevenueNet incomeNet margin

Q2 FY22Q4 FY22Q2 FY23Q4 FY23Q2 FY24Q4 FY24Q2 FY25Q4 FY25
Revenue$16.2M$17.7M$15.9M$23.8M$18.1M$23.4M$14.3M$10.3M
Net income$4.3M$3.5M$1.4M$7.0M$767.0K−$6.9M−$9.4M−$12.6M
Net margin26.8%19.8%8.5%29.3%4.2%0.0%0.0%0.0%

GrowthOperating income

Q2 FY22Q4 FY22Q2 FY23Q4 FY23Q2 FY24Q4 FY24Q2 FY25Q4 FY25
Operating income$5.8M$4.9M$2.9M$9.4M$1.7M−$6.3M−$5.2M−$9.2M
YoY growth−13.5%+5.4%−50.6%+92.8%−40.3%−166.5%−408.3%

Balance sheet, Dec 31, 2025Cash & short-term investments $26.9M · Total debt $554.0K · Total assets $75.6M · Shareholders' equity $70.6M

Revenue
$10.3M
Operating income
−$9.2M
Net income
−$12.6M
View details

No dividends on record.

Institutions1 holder · as of Mar 31, 20260.04%334 ADS
Otherremainder99.96%761.5K ADS

761.8K ADS (1 ADS = 30 ordinary shares) as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

The share count is from the company's Dec 2022 annual report; nothing newer is on file here.

This company has 2 share classes; every stake here is a share of the whole company.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
UBS Group AGInstitution
0.04%167 A ADS · 167 A ADS13Fas of Mar 31, 2026

13F — a manager's quarterly holdings

Insider tradesForm 4

Nothing filed in the last 12 months.

View details

Not reported.